Home/Filings/4/0001610717-24-000491
4//SEC Filing

Radhakrishnan Anup 4

Accession 0001610717-24-000491

CIK 0001966494other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 5:23 PM ET

Size

8.9 KB

Accession

0001610717-24-000491

Insider Transaction Report

Form 4
Period: 2024-09-18
Transactions
  • Sale

    Common Stock

    2024-09-18$25.28/sh1,600$40,4526,446 total
  • Exercise/Conversion

    Common Stock

    2024-09-18$5.03/sh+1,600$8,0488,046 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-09-181,60053,180 total
    Exercise: $5.03Exp: 2033-04-20Common Stock (1,600 underlying)
Footnotes (3)
  • [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 28, 2024.
  • [F2]This transaction was executed in multiple trades in prices ranging from $25.25 to $25.44, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]25% of the shares subject to the option vest on the first anniversary measured from February 9, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Documents

1 file

Issuer

CARGO Therapeutics, Inc.

CIK 0001966494

Entity typeother

Related Parties

1
  • filerCIK 0001999930

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 5:23 PM ET
Size
8.9 KB